Trial Profile
A phase III clinical study of Amphetamine (HLD-900) for the treatment of binge eating disorder
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs Dexamfetamine (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 05 Apr 2016 According to a Highland Therapeutics media release, this trial is expected to initiate in the second half of 2016.
- 17 Feb 2016 This trial is planned to be initiated in the year 2016.
- 17 Feb 2016 New trial record